ImmuCell
ICCC
ICCC
31 hedge funds and large institutions have $5.32M invested in ImmuCell in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $5.42M → $5.32M (-$103K)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$87.3K | |
| 2 | +$39K | |
| 3 | +$20.4K | |
| 4 |
Morgan Stanley
New York
|
+$18K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.3K |
Top Sellers
| 1 | -$72.7K | |
| 2 | -$61.1K | |
| 3 | -$29.3K | |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$13.2K |
| 5 |
Renaissance Technologies
New York
|
-$2.19K |